Role of Gpcpd1 in Intestinal Metabolism of Glycerophosphocholine
Author Information
Author(s): Chen Siyi, Inui Shiho, Aisyah Rahmawati, Nakashima Ryoko, Kawaguchi Tatsuya, Hinomoto Minori, Nakagawa Yoshiko, Sakuma Tetsushi, Sotomaru Yusuke, Ohshima Noriyasu, Kumrungsee Thanutchaporn, Ohkubo Takeshi, Yamamoto Takashi, Miura Yutaka, Suzuki Takuya, Yanaka Noriyuki
Primary Institution: Graduate School of Integrated Sciences for Life, Hiroshima University, Hiroshima, Japan
Hypothesis
This study aims to explore the mechanisms underlying the intestinal absorption and metabolism of glycerophosphocholine (GPC).
Conclusion
Gpcpd1 is a key enzyme that regulates the metabolism of GPC and affects TMAO levels in the bloodstream.
Supporting Evidence
- GPC supplementation increased blood TMAO levels in mice.
- Gpcpd1 knockdown in Caco-2 cells reduced choline levels in the medium.
- Gpcpd1-deficient mice showed altered GPC metabolism and lower TMAO levels after GPC administration.
- Choline levels increased in the portal vein after GPC administration.
- Extracellular GPC-hydrolyzing activity was observed in conditioned medium from Caco-2 cells.
Takeaway
This study shows that a specific enzyme helps break down a nutrient called glycerophosphocholine in the gut, which can affect levels of a compound linked to heart disease.
Methodology
The study involved in vitro experiments with Caco-2 cells and in vivo experiments with Gpcpd1-deficient mice to assess GPC metabolism and TMAO production.
Limitations
The study primarily focuses on mouse models, which may not fully replicate human metabolism.
Participant Demographics
6-week-old male C57BL/6J mice were used for in vivo experiments.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website